• IGI Therapeutics SA, succursale d'Epalinges

    VD
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-550.1.250.581-3
    Sector: Research and development

    Age of the company

    3 months

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    Capital unknown

    Employees

    PremiumPremium

    Active brands

    0

    Reports for IGI Therapeutics SA, succursale d'Epalinges

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About IGI Therapeutics SA, succursale d'Epalinges

    • IGI Therapeutics SA, succursale d'Epalinges is currently active and the industry «Research and development». The legal headquarters are in Epalinges.
    • The management consists of 0 persons. The company was founded on 03.06.2025.
    • The last commercial register change was made on 06.06.2025. All changes can be viewed under the section «Notifications» and saved as a PDF.
    • The reported UID is CHE-218.656.750.
    • On the same address there are 13 other active companies registered. These include: A3P Suisse, Abionic SA, Exogems SA.

    Management

    No managers have been registered.

    Source: SOGC

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Acquisition, exploitation, vente et cession en licence de tous les biens relevant de la propriété intellectuelle et industrielle (brevets, marques, inventions, dessins, modèles); fabrication, directement ou par sous-traitance, de tous produits phamarmaceutiques; recherche et développement; accorder des prêts ou des garanties à des actionnaires ou des tiers, dans l'intérêt de la société.

    Customise the company purpose with just a few clicks.

    Other company names

    Source: SOGC

    Past and translated company names

    • IGI Therapeutics AG, Zweigniederlassung von Epalinges
    • IGI Therapeutics Ltd, branch office of Epalinges
    Would you like to update the company name? Click here.

    Head office

    IGI Therapeutics SA in La Chaux-de-Fonds

    Other branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: IGI Therapeutics SA, succursale d'Epalinges

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250606/2025 - 06.06.2025
    Categories: Company foundation

    Publication number: HR01-1006350549, Commercial Registry Office Vaud, (550)

    IGI Therapeutics SA, succursale d'Epalinges (IGI Therapeutics AG, Zweigniederlassung von Epalinges) (IGI Therapeutics Ltd, branch office of Epalinges), à Epalinges, Route de la Corniche 5, 1066 Epalinges, CHE-218.656.750. Nouvelle succursale d'une entreprise suisse. Succursale de IGI Therapeutics SA (IGI Therapeutics AG) (IGI Therapeutics Ltd) (CHE-111.750.689), à La Chaux-de-Fonds, société anonyme.

    Title
    Confirm